Clínica Dermatológica do Hospital do Servidor Público Municipal de São Paulo, São Paulo, Brazil.
Dermatol Surg. 2011 Nov;37(11):1553-65. doi: 10.1111/j.1524-4725.2011.02087.x. Epub 2011 Jul 21.
Botulinum toxin (BoNT) has been in use since the late 1970s, and over the last 20 years, its use has been extended to new indications in various areas of medicine. During these years of clinical use, some of the initial ideas have changed, and others have remained stable along with increasing experience with and knowledge about BoNTs.
To review the literature and prescribing information on all of the available products and to update the concept of handling toxins (preparations, reconstitution, storage, sterility, and dilution).
A review (not Cochrane type analysis) of the medical literature based on relevant databases (MEDLINE, PubMed, Cochrane Library, specialist textbooks, and manufacturer information) was performed.
Many of the precautions around BoNT use, often recommended by the manufacturers, are described in the clinical literature as too restrictive. The literature suggests that toxins may be sturdier and more-resistant to degradation than previously understood.
肉毒毒素(BoNT)自 20 世纪 70 年代末开始使用,在过去的 20 年中,其应用范围已扩展到医学各领域的新适应证。在这些年的临床应用中,一些最初的观念发生了变化,而另一些观念则随着对 BoNTs 的认识和经验的增加而保持稳定。
综述所有可获得产品的文献和说明书,更新关于毒素(制剂、复溶、储存、无菌和稀释)处理的概念。
基于相关数据库(MEDLINE、PubMed、Cochrane 图书馆、专业教科书和制造商信息)对医学文献进行了回顾(非 Cochrane 类型分析)。
制造商经常推荐的许多 BoNT 使用注意事项在临床文献中被描述为过于严格。文献表明,毒素可能比以前认为的更坚固,对降解的抵抗力更强。